Abstract
Hyperphosphatemia is an important independent risk factor for both cardiovascular calcification and cardiovascular morbidity and mortality in dialysis patients.1-3 Serum phosphate levels are monitored routinely in patients on maintenance dialysis therapy, with high levels usually ascribed to nonadherence to diet or oral phosphate binders.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
